Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Learn what you need to know about cash back taxes to optimize your financial strategies. Stay ahead in tax planning.
25,545 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Si-Bone stock soared almost 20% on Tuesday as investors reacted to strong quarterly results and optimistic guidance. ...
Advanced Micro Devices stock rallied more than 8% on a Wednesday as software gains lifted the tech sector. Learn what...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...
A landmark agreement between Apple and Broadcom signals a major shift in chip strategy and domestic manufacturing. Th...
SoFi Technologies is not your average fintech. This article explores how customer growth, cross-sell momentum, and pr...
A significant stake in Clearwater Analytics has sparked renewed interest in the company’s SaaS-driven investment acco...
Explore ibotta (ibta) 2025 earnings projections, including revenue drivers, user growth, and profitability timelines....
Portillo's has faced growth and branding challenges that threaten its future. This guide breaks down what a comeback ...
When a large investor makes a bold move, the spotlight shifts from fundamentals to signals. This article unpacks how ...
Oracle has big cloud plans, aiming for massive revenue growth by 2030. A pivotal $110 billion catalyst could make tha...
As AMD prepares to report its second-quarter results, a bullish outlook centered on AI demand could dominate the conv...